Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease

Journal of Infectious Diseases

Volumn 199, Issue 6, 2009, Pages 847-857

  Gorse, Geoffrey J ^a,b,e   O'Connor, Theresa Z ^c   Hall, Susan L ^b   Vitale, Joseph N ^c   Nichol, Kristin L ^d  

^a Affairs Medical Center   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c Department of Veterans   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ACUTE RESPIRATORY TRACT DISEASE; ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONAVIRUS; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; VIRUS STRAIN;

ACUTE DISEASE; AGED; ANTIBODIES, VIRAL; CORONAVIRUS; CORONAVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEASONS; SPIROMETRY;

EID: 65649127759     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597122     Document Type: Article

References (50)

1. McIntosh K, Anderson LJ. Coronaviruses, including severe acute respiratory syndrome (SARS)-associated coronavirus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 6th ed. Vol 2. Philadelphia: Elsevier Churchill Livingstone, 2005:1990-7.
2. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1986-94.
3. Peiris JSM, Yuen KY, Osterhaus ADME, Stöhr K. The severe acute respiratory syndrome. N Engl J Med 2003; 349:2431-41.
4. Gump DW, Phillips CA, Forsyth BR, McIntosh K, Lamborn KR, Stouch WH. Role of infection in chronic bronchitis. Am Rev Respir Dis 1976; 113:465-74.
5. Buscho RO, Saxtan D, Shultz PS, Finch E, Mufson MA. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis 1978; 137:377-83.
6. Smith CB, Golden CA, Kanner RE, Renzetti AD Jr. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary disease.AmRev Respir Dis 1980; 121:225-32.
7. Fagon J-Y, Chastre J. Severe exacerbations of COPD patients: the role of pulmonary infections. Semin Respir Infect 1996; 11:109-18.
8. Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease.AmJ Respir Crit Care Med 2000; 162:167-73.
9. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000; 283:499-505.
10. El-SahlyHM,Atmar RL, Glezen WP, Greenberg SB. Spectrum of clinical illness in hospitalized patients with "common cold" virus infections. Clin Infect Dis 2000; 31:96-100.
11. Falsey AR, Walsh EE, Hayden FG. Rhinovirus and coronavirus infection-associated hospitalizations among older adults. J Infect Dis 2002; 185:1338-41.
12. Graat JM, Schouten EG, Heijnen M-LA, et al. A prospective, community-based study on virologic assessment among elderly people with and without symptoms of acute respiratory infection. J Clin Epidemiol 2003; 56:1218-23.
13. Falsey AR, Walsh EE. Viral pneumonia in older adults. Clin Infect Dis 2006; 42:518-24.
14. Mallia P, Johnston SL. How viral infections cause exacerbation of airway diseases. Chest 2006;30:1203-10.
15. Vabret A, Mourez T, Gouarin S, Petitjean J, Freymuth F. An outbreak of coronavirus OC43 respiratory infection in Normandy, France. Clin Infect Dis 2003; 36:985-9.
16. van Elden LJR, van Loon AM, van Alphen F, et al. Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. J Infect Dis 2004; 189:652-7.
17. Pyrc K, Berkhout B, Van Der Hoek L. The novel coronaviruses NL63 and HKU1. J Virol 2007; 81:3051-7.
18. van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med 2004; 10:368-73.
19. Fouchier RAM, Hartwig NG, Bestebroer TM, et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci USA 2004; 101:6212-6.
20. Vabret A, Mourez T, Dina J, et al. Human coronavirus NL63, France. Emerg Infect Dis 2005; 11:1225-9.
21. Moës E, Vijgen L, Keyaerts E, et al. A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis 2005; 5:6.
22. Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis 2005; 191:492-8.
23. Garbino J, Crespo S, Aubert J-D, et al. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (non-SARS)-related human coronavirus infection. Clin Infect Dis 2006; 43:1009-15.
24. Arden KE, Nissen MD, Sloots TP, Mackay IM. New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J Med Virol 2005; 75:455-62.
25. Bastien N, Anderson K, Hart L, et al. Human coronavirus NL63 infection in Canada. J Infect Dis 2005; 191:503-6.
26. Chiu SS, Chan KH, Chu KW, et al. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin Infect Dis 2005; 40:1721-9.
27. Woo PCY, Lau SKP, Tsoi H-W, et al. Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J Infect Dis 2005; 192:1898-907.
28. Woo PCY, Lau SKP, Chu C-M, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 2005; 79:884-95.
29. Vabret A, Dina J, Gouarin S, Petitjean J, Corbet S, Freymuth F. Detection of the new human coronavirus HKU1:Areport of 6 cases. Clin Infect Dis 2006; 42:634-9.
30. Lau SKP, Woo PCY, Yip CCY, et al. Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol 2006; 44:2063-71.
31. Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Coronavirus HKU1 infection in the United States. Emerg Infect Dis 2006; 12:775-9.
32. Sloots TP, McErlean P, Speicher DJ, Arden KE, Nissen MD, Mackay IM. Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol 2006; 35:99-102.
33. Shao X, Guo X, Esper F, Weibel C, Kahn JS. Seroepidemiology of group I human coronaviruses in children. J Clin Virol 2007; 40:207-13.
34. Kistler A, Avila PC, Rouskin S, et al. Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis 2007; 196:817-25.
35. Gorse GJ, O'Connor TZ, Young SL, et al. Efficacy trial of live, coldadapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: aVA cooperative study. Vaccine 2003; 21:2133-44.
36. Medical Section of the American Lung Association, American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-36.
37. Medical Section of the American Lung Association, American Thoracic Society. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis 1991; 144:1202-18.
38. The hemagglutination inhibition test for influenza viruses. Atlanta, GA: Centers for Disease Control and Prevention, World Health Organization, 1975.
39. Dowdle WR, Kendal AP, Noble GR. Influenza viruses. In: Lennette EH, Schmidt NJ, eds. Diagnostic procedures for viral, rickettsial, and chlamydial infections. 5th ed. Washington, DC: American Public Health Association, 1979:585-609.
40. Hanson CV, Riggs JL, Lennette EH. Photochemical inactivation ofDNA and RNA viruses by psoralen derivatives. J Gen Virol 1978; 40:345-58.
41. Redfield DC, Richman DD, Oxman MN, Kronenberg LH. Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells. Infect Immun 1981; 32:1216-26.
42. Reizenstein E, Hallander H-O, Blackwelder WC, Kühn I, Ljungman M, Möllby R. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods 1995; 183:279-90.
43. Selim AJ, Ren XS, Fincke G, Rogers W, Lee A, Kazis L. A symptom-based measure of the severity of chronic lung disease: results from the Veterans Health Study. Chest 1997; 111:1607-14.
44. Kazis LE, Miller DR, Skinner KM, et al. Patient-reported measures of health, the veterans health study. J Ambul Care Manage 2004; 27:70-83.
45. Skinner KM, Miller DR, Spiro A III, et al. Measurement strategies designed and tested in the veterans health study. J Ambul Care Manage 2004; 27:180-9.
46. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-68.
47. Gorse GJ, O'Connor TZ, Young SL, et al. Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination. Chest 2006; 130:1109-16.
48. Neuzil KM, O'Connor TZ, Gorse GJ, Nichol KL. Recognizing influenza illness in influenza-vaccinated, older patients with chronic obstructive pulmonary disease. Clin Infect Dis 2003; 36:169-74.
49. Dare RK, Fry AM, Chittaganpitch M, Sawanpanyalert P, Olsen SJ, Erdman DD. Human coronavirus infections in rural Thailand: a comprehensive study using real-time reverse-transcription polymerase chain reaction assays. J Infect Dis 2007; 196:1321-8.
50. Kuypers J, Martin ET, Heugel J, Wright N, Morrow R, Englund JA. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics 2007; 119:e70-6.